StonvexLoading…
StonvexStonvexStonvexCore line items from JAKK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $106.68M | $113.25M | $443.56M | $232.35M |
Operating Income | $-5.57M | $14.22M | $22.82M | $-6.54M |
Net Income | $-4.28M | $9.87M | $15.19M | $-2.32M |
EPS (Diluted) | $-0.37 | $0.86 | $1.32 | $-0.42 |
Total Assets | $400.45M | $442.20M | $485.27M | $438.72M |
Total Liabilities | $158.46M | $193.09M | $229.35M | $201.98M |
Cash & Equivalents | $62.85M | $52.20M | $25.89M | $38.20M |
Free Cash Flow OCF − CapEx | $16.21M | $-1.07M | $-32.60M | $-20.40M |
Shares Outstanding | 11.44M | 11.34M | 11.20M | 11.15M |